CDKAL1 and gestational diabetes: The complex relationship between inflammatory pathways, genetics, CVD and GDM necessitates further research to develop targeted gene therapy and therapeutic drugs aimed at addressing genetic variations in SLC30A8, CDKAL1, TCF7L2, IRS1, GCK, and related genes.